Advancing Research
by funding Grant Programs and Fellowships
Driving Innovation
by guiding studies such as the FAST Initiative, the SuperAgers Initiative, and the TAME Trial
Furthering the Field
by supporting the infrastructure of three NIA Initiatives and leading the Amplifying Geroscience Initiative.
Top Breakthroughs driven by AFAR Experts
Delaying Disease by Targeting Aging
Saving Costs by Extending Healthspan
What are the Hallmarks of Aging?
What is Geroscience?
What is the Longevity Dividend?
Posted May 9, 2017
On May 1, 2017, AFAR Deputy Scientific Director, Nir Barzilai, MD was a featured expert in the panel, Will You Live to a Healthy 100?, at the Milken Institute 2017 Global Conference.
Alongside Director of the National Institutes of Health, Francis Collins, MD, PhD; Nobel laureate and President of the Salk Institute, Elizabeth Blackburn, PhD; Dean of USC Leonard Davis School of Gerontology, Pinchas Cohen, MD; and President of Palo Alto Investors, Joon Yun, MD, Barzilai explored the discoveries that are bringing us closer to understanding the aging process.
The discussion asked: what can geroscience teach us about increasing both life span and health span, what game-changing and life-changing research is in the pipeline, and how can investors and philanthropists get involved in research that will change life as we know it.
